EGFR and breast carcinoma: The stringent up-regulation of SGK1 in response to progesterone led to an activation of a tumor metastasis suppressor gene, NDRG1, via a set of AP-1 network genes to inactivate AKT1, ERK1/2, and EGFR kinases, impeding the invasion and migration of breast cancer cells.